A WAIS-R marker for accelerated aging and dementia, Alzheimer's type? Base rates of the Fuld formula in the WAIS-R standardization sample.
Recent reports have provided evidence that a WAIS-R marker for dementia of the Alzheimer's type (DAT) may have value in differential clinical diagnosis. Using the Fuld (1984) formula, this study investigated the prevalence of the WAIS-R marker in the WAIS-R standardization sample (N = 1,880), whose members range in age from 16 to 74 years. The results from the WAIS-R sample suggest no significant age differences in the occurrence of this marker when age-corrected scaled scores are employed. Across age, the occurrence of this marker is about 6.2%. Although there were no significant effects according to race, there were significant sex (males = 7.34%; females = 5.11%) and education effects. For individuals aged 65-74 with some post high school education, the base rate was about 14%. These findings are discussed as they relate to the potential clinical usefulness of this marker in the differential diagnosis of DAT.